Obstetric, neonatal, and child health outcomes following embryo biopsy for preimplantation genetic testing
Abstract BACKGROUND Preimplantation genetic testing (PGT) of embryos developed in vitro requires a biopsy for obtaining cellular samples for the analysis. Signs of cell injury have been described in association with this procedure. Thus, the consequences of the biopsy on obstetric and neonatal outco...
Uloženo v:
| Vydáno v: | Human reproduction update Ročník 29; číslo 3; s. 291 - 306 |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Oxford University Press
02.05.2023
|
| Témata: | |
| ISSN: | 1355-4786, 1460-2369, 1460-2369 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Abstract
BACKGROUND
Preimplantation genetic testing (PGT) of embryos developed in vitro requires a biopsy for obtaining cellular samples for the analysis. Signs of cell injury have been described in association with this procedure. Thus, the consequences of the biopsy on obstetric and neonatal outcomes have been the subject of some quantitative analyses, although the reliability of data pooling may be limited by important issues in the various reports.
OBJECTIVE AND RATIONALE
The present review identifies evidence for whether pregnancies conceived after embryo biopsy are associated with a higher risk of adverse obstetric, neonatal, and long-term outcomes. Available evidence has been summarized considering manipulation at various stages of embryo development.
SEARCH METHODS
We used the scoping review methodology. Searches of article databases were performed with keywords pertaining to the embryo biopsy technique and obstetric, neonatal, and postnatal outcomes. Studies in which embryos were biopsied at different stages (i.e. both at the cleavage and blastocyst stages) were excluded. We included data on fresh and frozen embryo transfers. The final sample of 31 documents was subjected to qualitative thematic analysis.
OUTCOMES
Sound evidence is lacking to fully address the issues on the potential obstetric, neonatal or long-term consequences of embryo biopsy. For polar body biopsy, the literature is too scant to draw any conclusion. Some data, although limited and controversial, suggest a possible association of embryo biopsy at the cleavage stage with an increased risk of low birthweight and small for gestational age neonates compared to babies derived from non-biopsied embryos. An increase in preterm deliveries and birth defects in cases of trophectoderm biopsy was suggested. For both biopsy methods (at the cleavage and blastocyst stages), an increased risk for hypertensive disorders of pregnancy was found. However, these findings may be explained by confounders such as other embryo manipulation procedures or by intrinsic patient or population characteristics.
WIDER IMPLICATIONS
Since there is inadequate evidence to assess obstetric, neonatal, and long-term health outcomes following embryo biopsy, an invasive PGT strategy should be developed with a cautious approach. A non-invasive approach, based on the analysis of embryo cell-free DNA, needs to be pursued to overcome the potential limitations of embryo biopsy.
Graphical abstract
No conclusive evidence for an adverse effect of PGT on outcomes. The amber symbol represents weak and/or a controversial body of safety evidence for which further research is required. The red symbol warns that no evidence of safety exists. PGT, preimplantation genetic testing. |
|---|---|
| AbstractList | Preimplantation genetic testing (PGT) of embryos developed in vitro requires a biopsy for obtaining cellular samples for the analysis. Signs of cell injury have been described in association with this procedure. Thus, the consequences of the biopsy on obstetric and neonatal outcomes have been the subject of some quantitative analyses, although the reliability of data pooling may be limited by important issues in the various reports.BACKGROUNDPreimplantation genetic testing (PGT) of embryos developed in vitro requires a biopsy for obtaining cellular samples for the analysis. Signs of cell injury have been described in association with this procedure. Thus, the consequences of the biopsy on obstetric and neonatal outcomes have been the subject of some quantitative analyses, although the reliability of data pooling may be limited by important issues in the various reports.The present review identifies evidence for whether pregnancies conceived after embryo biopsy are associated with a higher risk of adverse obstetric, neonatal, and long-term outcomes. Available evidence has been summarized considering manipulation at various stages of embryo development.OBJECTIVE AND RATIONALEThe present review identifies evidence for whether pregnancies conceived after embryo biopsy are associated with a higher risk of adverse obstetric, neonatal, and long-term outcomes. Available evidence has been summarized considering manipulation at various stages of embryo development.We used the scoping review methodology. Searches of article databases were performed with keywords pertaining to the embryo biopsy technique and obstetric, neonatal, and postnatal outcomes. Studies in which embryos were biopsied at different stages (i.e. both at the cleavage and blastocyst stages) were excluded. We included data on fresh and frozen embryo transfers. The final sample of 31 documents was subjected to qualitative thematic analysis.SEARCH METHODSWe used the scoping review methodology. Searches of article databases were performed with keywords pertaining to the embryo biopsy technique and obstetric, neonatal, and postnatal outcomes. Studies in which embryos were biopsied at different stages (i.e. both at the cleavage and blastocyst stages) were excluded. We included data on fresh and frozen embryo transfers. The final sample of 31 documents was subjected to qualitative thematic analysis.Sound evidence is lacking to fully address the issues on the potential obstetric, neonatal or long-term consequences of embryo biopsy. For polar body biopsy, the literature is too scant to draw any conclusion. Some data, although limited and controversial, suggest a possible association of embryo biopsy at the cleavage stage with an increased risk of low birthweight and small for gestational age neonates compared to babies derived from non-biopsied embryos. An increase in preterm deliveries and birth defects in cases of trophectoderm biopsy was suggested. For both biopsy methods (at the cleavage and blastocyst stages), an increased risk for hypertensive disorders of pregnancy was found. However, these findings may be explained by confounders such as other embryo manipulation procedures or by intrinsic patient or population characteristics.OUTCOMESSound evidence is lacking to fully address the issues on the potential obstetric, neonatal or long-term consequences of embryo biopsy. For polar body biopsy, the literature is too scant to draw any conclusion. Some data, although limited and controversial, suggest a possible association of embryo biopsy at the cleavage stage with an increased risk of low birthweight and small for gestational age neonates compared to babies derived from non-biopsied embryos. An increase in preterm deliveries and birth defects in cases of trophectoderm biopsy was suggested. For both biopsy methods (at the cleavage and blastocyst stages), an increased risk for hypertensive disorders of pregnancy was found. However, these findings may be explained by confounders such as other embryo manipulation procedures or by intrinsic patient or population characteristics.Since there is inadequate evidence to assess obstetric, neonatal, and long-term health outcomes following embryo biopsy, an invasive PGT strategy should be developed with a cautious approach. A non-invasive approach, based on the analysis of embryo cell-free DNA, needs to be pursued to overcome the potential limitations of embryo biopsy.WIDER IMPLICATIONSSince there is inadequate evidence to assess obstetric, neonatal, and long-term health outcomes following embryo biopsy, an invasive PGT strategy should be developed with a cautious approach. A non-invasive approach, based on the analysis of embryo cell-free DNA, needs to be pursued to overcome the potential limitations of embryo biopsy. Preimplantation genetic testing (PGT) of embryos developed in vitro requires a biopsy for obtaining cellular samples for the analysis. Signs of cell injury have been described in association with this procedure. Thus, the consequences of the biopsy on obstetric and neonatal outcomes have been the subject of some quantitative analyses, although the reliability of data pooling may be limited by important issues in the various reports. The present review identifies evidence for whether pregnancies conceived after embryo biopsy are associated with a higher risk of adverse obstetric, neonatal, and long-term outcomes. Available evidence has been summarized considering manipulation at various stages of embryo development. We used the scoping review methodology. Searches of article databases were performed with keywords pertaining to the embryo biopsy technique and obstetric, neonatal, and postnatal outcomes. Studies in which embryos were biopsied at different stages (i.e. both at the cleavage and blastocyst stages) were excluded. We included data on fresh and frozen embryo transfers. The final sample of 31 documents was subjected to qualitative thematic analysis. Sound evidence is lacking to fully address the issues on the potential obstetric, neonatal or long-term consequences of embryo biopsy. For polar body biopsy, the literature is too scant to draw any conclusion. Some data, although limited and controversial, suggest a possible association of embryo biopsy at the cleavage stage with an increased risk of low birthweight and small for gestational age neonates compared to babies derived from non-biopsied embryos. An increase in preterm deliveries and birth defects in cases of trophectoderm biopsy was suggested. For both biopsy methods (at the cleavage and blastocyst stages), an increased risk for hypertensive disorders of pregnancy was found. However, these findings may be explained by confounders such as other embryo manipulation procedures or by intrinsic patient or population characteristics. Since there is inadequate evidence to assess obstetric, neonatal, and long-term health outcomes following embryo biopsy, an invasive PGT strategy should be developed with a cautious approach. A non-invasive approach, based on the analysis of embryo cell-free DNA, needs to be pursued to overcome the potential limitations of embryo biopsy. Abstract BACKGROUND Preimplantation genetic testing (PGT) of embryos developed in vitro requires a biopsy for obtaining cellular samples for the analysis. Signs of cell injury have been described in association with this procedure. Thus, the consequences of the biopsy on obstetric and neonatal outcomes have been the subject of some quantitative analyses, although the reliability of data pooling may be limited by important issues in the various reports. OBJECTIVE AND RATIONALE The present review identifies evidence for whether pregnancies conceived after embryo biopsy are associated with a higher risk of adverse obstetric, neonatal, and long-term outcomes. Available evidence has been summarized considering manipulation at various stages of embryo development. SEARCH METHODS We used the scoping review methodology. Searches of article databases were performed with keywords pertaining to the embryo biopsy technique and obstetric, neonatal, and postnatal outcomes. Studies in which embryos were biopsied at different stages (i.e. both at the cleavage and blastocyst stages) were excluded. We included data on fresh and frozen embryo transfers. The final sample of 31 documents was subjected to qualitative thematic analysis. OUTCOMES Sound evidence is lacking to fully address the issues on the potential obstetric, neonatal or long-term consequences of embryo biopsy. For polar body biopsy, the literature is too scant to draw any conclusion. Some data, although limited and controversial, suggest a possible association of embryo biopsy at the cleavage stage with an increased risk of low birthweight and small for gestational age neonates compared to babies derived from non-biopsied embryos. An increase in preterm deliveries and birth defects in cases of trophectoderm biopsy was suggested. For both biopsy methods (at the cleavage and blastocyst stages), an increased risk for hypertensive disorders of pregnancy was found. However, these findings may be explained by confounders such as other embryo manipulation procedures or by intrinsic patient or population characteristics. WIDER IMPLICATIONS Since there is inadequate evidence to assess obstetric, neonatal, and long-term health outcomes following embryo biopsy, an invasive PGT strategy should be developed with a cautious approach. A non-invasive approach, based on the analysis of embryo cell-free DNA, needs to be pursued to overcome the potential limitations of embryo biopsy. Graphical abstract No conclusive evidence for an adverse effect of PGT on outcomes. The amber symbol represents weak and/or a controversial body of safety evidence for which further research is required. The red symbol warns that no evidence of safety exists. PGT, preimplantation genetic testing. |
| Author | Pozzoni, Mirko Viganò, Paola Gaeta, Gerarda Cavoretto, Paolo Ivo Cermisoni, Greta Chiara Alteri, Alessandra |
| Author_xml | – sequence: 1 givenname: Alessandra surname: Alteri fullname: Alteri, Alessandra – sequence: 2 givenname: Greta Chiara surname: Cermisoni fullname: Cermisoni, Greta Chiara – sequence: 3 givenname: Mirko orcidid: 0000-0002-8590-5743 surname: Pozzoni fullname: Pozzoni, Mirko – sequence: 4 givenname: Gerarda surname: Gaeta fullname: Gaeta, Gerarda – sequence: 5 givenname: Paolo Ivo surname: Cavoretto fullname: Cavoretto, Paolo Ivo – sequence: 6 givenname: Paola orcidid: 0000-0003-3674-5912 surname: Viganò fullname: Viganò, Paola email: paola.vigano@policlinico.mi.it |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36655536$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kEtLxDAQgIOs6K569Sg5Klg3jyZpjyK-QPCi55Ims7tZ2qQ2KbL_3siunmaY-ebBt0AzHzwgdEnJHSU1X26mfhrs0vbaEkKP0JyWkhSMy3qWcy5EUapKnqJFjNsMSFqpE3TKpRRCcDlH2_c2JkijM7fYQ_A66e4Wa2-x2bjO4g3oLm1wmJIJPUS8Cl0Xvp1fY-jbcRdw68IQd7k-4mEE1w-d9kknFzxeg4fkDE4QU544R8cr3UW4OMQz9Pn0-PHwUry9P78-3L8VpmQiFQwUMaSSpSyZpVJVQEy5UsbI_LRmGjjjUNNWVitQbS1sqbQWomKC1FYQw8_Q9X7vMIavKd9uehcNdPkxCFNsmJKKKlpzldGrAzq1PdhmGF2vx13z5ycDN3sgTMN_l5Lm132zd98c3PMfitt6OA |
| CitedBy_id | crossref_primary_10_1007_s10815_025_03641_z crossref_primary_10_3390_diagnostics15111375 crossref_primary_10_1111_jog_15804 crossref_primary_10_1111_1471_0528_18280 crossref_primary_10_17116_repro20253103163 crossref_primary_10_1093_humrep_dead238 crossref_primary_10_1007_s10815_023_02926_5 crossref_primary_10_1016_j_rbmo_2024_104490 crossref_primary_10_1016_j_bpobgyn_2024_102526 crossref_primary_10_1186_s40001_025_02457_y crossref_primary_10_3390_jpm15070268 crossref_primary_10_1093_humupd_dmae012 crossref_primary_10_1007_s10815_024_03078_w crossref_primary_10_1080_19396368_2024_2306389 crossref_primary_10_1093_humupd_dmae031 crossref_primary_10_3389_fcell_2023_1164757 crossref_primary_10_1016_j_xfre_2024_01_005 crossref_primary_10_1016_j_rbmo_2023_103327 crossref_primary_10_3390_genes16020134 crossref_primary_10_2298_MPNS2404083J crossref_primary_10_3389_fgene_2025_1599088 crossref_primary_10_3390_reprodmed5030011 crossref_primary_10_1002_mrd_23727 crossref_primary_10_1016_j_fertnstert_2024_05_152 crossref_primary_10_1007_s10815_025_03655_7 crossref_primary_10_7759_cureus_57357 crossref_primary_10_1016_j_arcmed_2024_103068 crossref_primary_10_1073_pnas_2424459122 crossref_primary_10_1016_j_ejogrb_2024_04_033 crossref_primary_10_1016_j_fertnstert_2023_06_013 crossref_primary_10_18502_ijrm_v22i3_16161 crossref_primary_10_3390_genes16050552 crossref_primary_10_1136_jme_2023_109195 crossref_primary_10_3390_diagnostics15131606 crossref_primary_10_1093_humupd_dmae024 crossref_primary_10_1007_s10815_024_03358_5 crossref_primary_10_1186_s12884_023_05760_w crossref_primary_10_1186_s12958_023_01140_3 crossref_primary_10_1007_s10815_025_03617_z crossref_primary_10_1016_j_fertnstert_2024_07_012 crossref_primary_10_31083_j_ceog5104087 crossref_primary_10_1016_j_heliyon_2024_e31983 crossref_primary_10_1186_s12884_024_07080_z |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. 2023 The Author(s) 2023. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. |
| Copyright_xml | – notice: The Author(s) 2023. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. 2023 – notice: The Author(s) 2023. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. |
| DBID | TOX CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1093/humupd/dmad001 |
| DatabaseName | Open Access: Oxford University Press Open Journals Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: TOX name: Oxford Academic Open Access Journals url: https://academic.oup.com/journals/ sourceTypes: Publisher – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology Biology |
| EISSN | 1460-2369 |
| EndPage | 306 |
| ExternalDocumentID | 36655536 10.1093/humupd/dmad001 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- -E4 .2P .I3 .ZR 0R~ 18M 1TH 29I 2WC 4.4 482 48X 53G 5GY 5VS 5WA 5WD 6.Y 70D AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AASNB AAUAY AAUQX AAVAP AAWDT AAWTL ABEUO ABIXL ABJNI ABKDP ABNHQ ABNKS ABPTD ABQLI ABQNK ABQTQ ABSAR ABSMQ ABWST ABXVV ABZBJ ACCCW ACFRR ACGFO ACGFS ACMRT ACPQN ACPRK ACUFI ACUTJ ACUTO ACYHN ACZBC ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFSHK AFXAL AFXEN AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AGUTN AHMBA AHXPO AI. AIAGR AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APJGH APWMN AQDSO AQKUS ASPBG ATGXG ATTQO AVNTJ AVWKF AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM BZKNY C1A C45 CAG CDBKE COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EIHJH EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN M-Z M49 MBLQV MHKGH N9A NGC NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OCZFY ODMLO ODZKP OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD RD5 RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO SV3 TCURE TEORI TJX TMA TOX TR2 VH1 W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 ABDFA ABEJV ABGNP ABPQP ABVGC ADNBA AEMQT AHMMS AJNCP ALXQX CGR CUY CVF ECM EIF NPM 7X8 AHGBF AJBYB |
| ID | FETCH-LOGICAL-c425t-2e70c0864642d1678e0c4f7cc6665a2ae323e91b68fe7b95d47aa5582509d50c3 |
| IEDL.DBID | TOX |
| ISICitedReferencesCount | 42 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000916619600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1355-4786 1460-2369 |
| IngestDate | Wed Oct 01 09:59:38 EDT 2025 Thu Apr 03 07:07:41 EDT 2025 Wed Aug 28 03:18:07 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | preimplantation genetic testing follow-up neonatal outcomes blastocyst trophectoderm biopsy maternal outcomes embryo biopsy scoping review |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com The Author(s) 2023. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c425t-2e70c0864642d1678e0c4f7cc6665a2ae323e91b68fe7b95d47aa5582509d50c3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
| ORCID | 0000-0003-3674-5912 0000-0002-8590-5743 |
| OpenAccessLink | https://dx.doi.org/10.1093/humupd/dmad001 |
| PMID | 36655536 |
| PQID | 2767171937 |
| PQPubID | 23479 |
| PageCount | 16 |
| ParticipantIDs | proquest_miscellaneous_2767171937 pubmed_primary_36655536 oup_primary_10_1093_humupd_dmad001 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-05-02 |
| PublicationDateYYYYMMDD | 2023-05-02 |
| PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-02 day: 02 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Human reproduction update |
| PublicationTitleAlternate | Hum Reprod Update |
| PublicationYear | 2023 |
| Publisher | Oxford University Press |
| Publisher_xml | – name: Oxford University Press |
| SSID | ssj0016187 |
| Score | 2.565426 |
| SecondaryResourceType | review_article |
| Snippet | Abstract
BACKGROUND
Preimplantation genetic testing (PGT) of embryos developed in vitro requires a biopsy for obtaining cellular samples for the analysis.... Preimplantation genetic testing (PGT) of embryos developed in vitro requires a biopsy for obtaining cellular samples for the analysis. Signs of cell injury... |
| SourceID | proquest pubmed oup |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 291 |
| SubjectTerms | Biopsy Blastocyst Child Female Genetic Testing - methods Humans Infant, Newborn Outcome Assessment, Health Care Pregnancy Preimplantation Diagnosis - methods Reproducibility of Results Retrospective Studies |
| Title | Obstetric, neonatal, and child health outcomes following embryo biopsy for preimplantation genetic testing |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36655536 https://www.proquest.com/docview/2767171937 |
| Volume | 29 |
| WOSCitedRecordID | wos000916619600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JTsMwEB0BAsSFrSxlk0GIU6Nmd3IsiIoDlB5A6i1yYhuKyKIsoP49Eyf0UDjAJYoiJbb8Jpo3Hr8ZgEvXkzr3dE9zGZeaTaNQC01LaiYTOreZ50pbCYXv6WjkTSb-uC0WXfySwvet_msVVxnv85hxXSm1DMerexU8PU7m-QLXUK3wDPSeOKDnzsszLr6-oGP7QSeVWxlu_WNC27DZckcyaMDegSWR7EJnkGDcHM_IFVGnOdU2-S6sXX_frT-06fMOvD2GCGpdk79HElHvm7P3HmEJJ0rTTRpRJEmrEu1QFESikaSf6NyIiMN8lpJwmmbFDJ_nJMvFNM7eWSNdSggaYq2HJGVdtiN52YPn4e3TzZ3WNlvQIvxtS80UVI8wvrExIOEGujChR7akUYTxjcMQOsu0hG-ECK6goe9wmzLmIBLIOLijR9Y-rCRpIg6BIL6Oa0um-5LaIvQZkhhOJQZeSF-kb3bhAjEIsqacRtCkwa2gWdagXdYunH9DFKDF12kMhitTFYFJXYxBkXjSLhw02M2_ZeFkHcdyj_4yxDFs1M3j1fFF8wRWyrwSp7AafZTTIj-DZTrx8DoaP5wpY_sCNpjSnA |
| linkProvider | Oxford University Press |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Obstetric%2C+neonatal%2C+and+child+health+outcomes+following+embryo+biopsy+for+preimplantation+genetic+testing&rft.jtitle=Human+reproduction+update&rft.au=Alteri%2C+Alessandra&rft.au=Cermisoni%2C+Greta+Chiara&rft.au=Pozzoni%2C+Mirko&rft.au=Gaeta%2C+Gerarda&rft.date=2023-05-02&rft.pub=Oxford+University+Press&rft.issn=1355-4786&rft.eissn=1460-2369&rft.volume=29&rft.issue=3&rft.spage=291&rft.epage=306&rft_id=info:doi/10.1093%2Fhumupd%2Fdmad001&rft.externalDocID=10.1093%2Fhumupd%2Fdmad001 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1355-4786&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1355-4786&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1355-4786&client=summon |